2131 - 2140 of 9188 Results
Title
Year
-
OPENTitle: Neural closed-loop deep brain stimulation for freezing of gaitJournal Name: Brain StimulationPublisher: Elsevier BVVol: 13Issue #: 5Start Page: 1320End Page: 1322Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.brs.2020.06.018Best OA location URL: http://www.brainstimjrnl.com/article/S1935861X20301364/pdfCitation Count: 59
- Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease2018OPENTitle: Sex differences in progression to mild cognitive impairment and dementia in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 50Issue #:Start Page: 29End Page: 36Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.02.007Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5943177Citation Count: 141
-
OPENTitle: Pooled analysis of iron-related genes in Parkinson's disease: Association with transferrinJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 62Issue #:Start Page: 172End Page: 178Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2013.09.019Best OA location URL: https://www.sciencedirect.com/science/article/pii/S0969996113002659Citation Count: 87
-
OPENTitle: L-DOPA functionalized, multi-branched gold nanoparticles as brain-targeted nano-vehiclesJournal Name: Nanomedicine: Nanotechnology, Biology and MedicinePublisher: Elsevier BVVol: 15Issue #: 1Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nano.2018.08.011Best OA location URL: http://hdl.handle.net/10044/1/63483Citation Count: 100
-
OPENTitle: Quantitative proteomics identifies altered O‐GlcNAcylation of structural, synaptic and memory‐associated proteins in Alzheimer's diseaseJournal Name: The Journal of PathologyPublisher: WileyVol: 243Issue #: 1Start Page: 78End Page: 88Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/path.4929Best OA location URL: http://doi.org/10.1002/path.4929Citation Count: 141
- Deterioration of executive dysfunction in elderly with REM sleep behavior disorder (RBD)2018RESTRICTEDTitle: Deterioration of executive dysfunction in elderly with REM sleep behavior disorder (RBD)Journal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 70Issue #:Start Page: 242End Page: 246Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2018.06.029Citation Count: 17
-
OPENTitle: Free-water imaging of the hippocampus is a sensitive marker of Alzheimer's diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 24Issue #:Start Page: 101985End Page: 101985Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2019.101985Best OA location URL: https://doi.org/10.1016/j.nicl.2019.101985Citation Count: 69
- A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystonia2019RESTRICTEDTitle: A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystoniaJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 63Issue #:Start Page: 195End Page: 198Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.035Citation Count: 30
- Chemogenomic Profiling of Endogenous PARK2 Expression Using a Genome-Edited Coincidence Reporter2015OPENTitle: Chemogenomic Profiling of Endogenous PARK2 Expression Using a Genome-Edited Coincidence ReporterJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 10Issue #: 5Start Page: 1188End Page: 1197Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/cb5010417Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9927027Citation Count: 56
-
RESTRICTEDTitle: Discovery, Synthesis, and Preclinical Characterization ofN-(3-Chloro-4-fluorophenyl)-1H-pyrazolo[4,3-b]pyridin-3-amine (VU0418506), a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4)Journal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 7Issue #: 9Start Page: 1192End Page: 1200Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.6b00035Best OA location URL: http://doi.org/10.1021/acschemneuro.6b00035Citation Count: 46